CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation

Yingying Kumar, Simon Kung, Gen Shinozaki

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation'. Together they form a unique fingerprint.

Medicine & Life Sciences